Literature DB >> 20110612

Behavioral phenotyping of a transgenic Caenorhabditis elegans expressing neuronal amyloid-beta.

Laura E Dosanjh1, Marishka K Brown, Gautam Rao, Christopher D Link, Yuan Luo.   

Abstract

Alzheimer's disease (AD) is rapidly reaching epidemic proportions in the United States, currently affecting more than 5 million individuals and predicted to affect 14 million by 2050. Despite a general consensus that the amyloid-beta (Abeta) protein plays a significant role in disease progression, the underlying pathology of the disease is not entirely clear. Caenorhabditis elegans is a simple organism that has been used as a model for basic mechanistic studies on the underlying pathological processes involved in AD. Previous studies from our labs demonstrated that transgenic C. elegans with muscle specific expression of human Abeta undergo rapid paralysis, and worms with neuronal expression of Abeta show deficits in chemotaxis to volatile chemicals. In this study, we evaluate the effect of neuron specific expression of Abeta on multiple neuronally controlled behaviors in a transgenic C. elegans. These worms demonstrate deficits in odorant preference associative learning behavior, and the serotonin-controlled behaviors experience-dependent learning and egg laying. These newly identified learning-deficit behavioral phenotypes in the neuronal Abeta C. elegans suggest that the model may be used to elucidate underlying pathological events related to development of AD and for pharmaceutical intervention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110612     DOI: 10.3233/JAD-2010-1267

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  36 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

2.  Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegans.

Authors:  Luisa Diomede; Paola Rognoni; Francesca Lavatelli; Margherita Romeo; Andrea di Fonzo; Claudia Foray; Fabio Fiordaliso; Giovanni Palladini; Veronica Valentini; Vittorio Perfetti; Mario Salmona; Giampaolo Merlini
Journal:  Worm       Date:  2014-10-30

Review 3.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

Review 4.  Caenorhabditis elegans in Chinese medicinal studies: making the case for aging and neurodegeneration.

Authors:  Qiangqiang Wang; Fan Yang; Wei Guo; Ju Zhang; Lingyun Xiao; Haifeng Li; Weizhang Jia; Zebo Huang
Journal:  Rejuvenation Res       Date:  2014-04-08       Impact factor: 4.663

5.  The protection of novel 2-arylethenylquinoline derivatives against impairment of associative learning memory induced by neural Aβ in C. elegans Alzheimer's disease model.

Authors:  Qidi He; Guan Huang; Yixin Chen; Xiaoqin Wang; Zhishu Huang; Zuanguang Chen
Journal:  Neurochem Res       Date:  2017-07-01       Impact factor: 3.996

6.  Alzheimer's Disease Drug Discovery: In-vivo screening using C. elegans as a model for β-amyloid peptide-induced toxicity.

Authors:  Al Lublin; Cd Link
Journal:  Drug Discov Today Technol       Date:  2013

Review 7.  Caenorhabditis elegans as a model organism to study APP function.

Authors:  Collin Y Ewald; Chris Li
Journal:  Exp Brain Res       Date:  2011-10-29       Impact factor: 1.972

8.  Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease'.

Authors:  Srinivas Ayyadevara; Akshatha Ganne; Rachel D Hendrix; Meenakshisundaram Balasubramaniam; Robert J Shmookler Reis; Steven W Barger
Journal:  J Neurosci Methods       Date:  2018-11-06       Impact factor: 2.390

9.  Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein Aggregation.

Authors:  Srinivas Ayyadevara; Meenakshisundaram Balasubramaniam; Samuel Kakraba; Ramani Alla; Jawahar L Mehta; Robert J Shmookler Reis
Journal:  Antioxid Redox Signal       Date:  2017-06-28       Impact factor: 8.401

10.  Cinnamomum cassia bark in two herbal formulas increases life span in Caenorhabditis elegans via insulin signaling and stress response pathways.

Authors:  Young-Beob Yu; Laura Dosanjh; Lixing Lao; Ming Tan; Bum Sang Shim; Yuan Luo
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.